Active Shortage

TYENNE

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TYENNE in Canada?

Yes. TYENNE 162MG has an active shortage reported to Health Canada (last updated October 27, 2026).

Why is TYENNE not available?

The reason the manufacturer reported: Demand increase for the drug.

When will TYENNE be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file3 products · 0 same form & route

Affected strength162MG

Report last updated2026-10-27

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

ACTEMRA

HOFFMANN-LA ROCHE LIMITED

200MG · DIN 02350106

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

TYENNE

FRESENIUS KABI CANADA LTD

80MG · DIN 02552450

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

AVTOZMA

CELLTRION INC.

80MG · DIN 02562022

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02552485

Strength

162MG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

TOCILIZUMAB

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02267659